BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37955864)

  • 21. Androgens and male fertility.
    Dohle GR; Smit M; Weber RF
    World J Urol; 2003 Nov; 21(5):341-5. PubMed ID: 14566423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doping with testosterone and androgenic/anabolic steroids: Impact on health, screening tools and medical care.
    Young J
    Ann Endocrinol (Paris); 2023 May; 84(3):401-405. PubMed ID: 36990315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.
    Abdullah R; Bjørnebekk A; Hauger LE; Hullstein IR; Edvardsen T; Haugaa KH; Almaas VM
    Eur J Prev Cardiol; 2024 Mar; 31(5):599-608. PubMed ID: 37992194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs.
    Holterhus PM; Piefke S; Hiort O
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):269-75. PubMed ID: 12589933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Central Effects of Androgenic-anabolic Steroid Use.
    Mędraś M; Brona A; Jóźków P
    J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabolic steroid misuse and male infertility: management and strategies to improve patient awareness.
    Whitaker DL; Geyer-Kim G; Kim ED
    Expert Rev Endocrinol Metab; 2021 May; 16(3):109-122. PubMed ID: 33973822
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.
    Bahrke MS; Yesalis CE; Wright JE
    Sports Med; 1990 Nov; 10(5):303-37. PubMed ID: 2263798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous Androgens and Male Reproduction.
    Drobnis EZ; Nangia AK
    Adv Exp Med Biol; 2017; 1034():25-28. PubMed ID: 29256124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
    Yarrow JF; McCoy SC; Borst SE
    Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation and potentiation of anabolic and androgenic effects of steroids; testosterone and methyl-androstenediol.
    SAKAMOTO W; GORDAN GS; EISENBERG E
    Proc Soc Exp Biol Med; 1951 Feb; 76(2):406-8. PubMed ID: 14827941
    [No Abstract]   [Full Text] [Related]  

  • 31. [Myoanabolic steroids and selective androgen receptor modulators: mechanism of action and perspectives].
    Tóth M
    Orv Hetil; 2009 Nov; 150(45):2051-9. PubMed ID: 19861292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
    Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
    Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review.
    Esposito M; Salerno M; Calvano G; Agliozzo R; Ficarra V; Sessa F; Favilla V; Cimino S; Pomara C
    Panminerva Med; 2023 Mar; 65(1):43-50. PubMed ID: 35146992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinforcing aspects of androgens.
    Wood RI
    Physiol Behav; 2004 Nov; 83(2):279-89. PubMed ID: 15488545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anabolic-androgenic steroids and psychiatric-related effects: a review.
    Uzych L
    Can J Psychiatry; 1992 Feb; 37(1):23-8. PubMed ID: 1551042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactivity of 11 keto and hydroxy androgens in yeast and mammalian host cells.
    Handelsman DJ; Cooper ER; Heather AK
    J Steroid Biochem Mol Biol; 2022 Apr; 218():106049. PubMed ID: 34990809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. History and epidemiology of anabolic androgens in athletes and non-athletes.
    Kanayama G; Pope HG
    Mol Cell Endocrinol; 2018 Mar; 464():4-13. PubMed ID: 28245998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep pathology and use of anabolic androgen steroids among male weightlifters in Norway.
    Klonteig S; Scarth M; Bjørnebekk A
    BMC Psychiatry; 2024 Jan; 24(1):62. PubMed ID: 38254047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hair analysis as a powerful tool for the identification of anabolic androgenic steroids and other performance and image enhancing drugs in a subject with tissues damages.
    Odoardi S; Mestria S; Biosa G; Cittadini F; Senati M; Strano Rossi S
    Drug Test Anal; 2023 Sep; 15(9):1010-1017. PubMed ID: 37055374
    [No Abstract]   [Full Text] [Related]  

  • 40. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
    Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.